Ann Arbor, MI - July 2015 - ENDRA Life Sciences ( announced today that Michael Harsh has joined the firm’s Board of Directors to further develop the company’s breakthrough imaging platforms. Mr. Harsh has 36 years' experience in healthcare technology, focused on diagnostic imaging. He was most recently GE Healthcare’s Vice President and Chief Technology Officer, leading the global Science and Technology Organization and its research and development teams in diagnostics, healthcare IT and life sciences.

In 2004, Mr. Harsh was named Global Technology Leader – Imaging Technologies Lab at the GE Global Research Center, where he led the research for imaging technologies across the company as well as the research associated with computer visualization/image analysis and superconducting systems. He led Engineering for GE Industrial and Enterprise Solutions from 2006 to 2009. Mike was named an officer of the General Electric Company in November 2006.

In addition to his work at ENDRA, Mr. Harsh is a currently co-founder of Terapede Systems, a digital x-ray detector startup, a member of the Board of Directors of FloDesign Sonics, a member of the Scientific Advisory Board of Phoenix Nuclear labs and a consultant to start-ups in the medical device industry.

Mr. Harsh is a graduate of Marquette University in Milwaukee, Wisconsin, where he earned a bachelor’s degree in Electrical Engineering. He holds numerous U.S. patents in the field of medical imaging and instrumentation. In 2008, he was elected to the American Institute for Medical and Biological Engineering College of Fellows for his significant contributions to the medical and biological engineering field.

“Mike brings with him a wealth of experience and deep knowledge of the medical imaging space. We are very pleased to welcome him to ENDRA’s board. His appointment greatly enhances our ability to become the leading company in the field of thermoacoustics,” said Francois Michelon, ENDRA’s CEO and Board Chairman.

About ENDRA Life Sciences

ENDRA Life Science’s mission is to bring new capabilities to ultrasound. ENDRA has assembled a world class team of scientific, clinical, and commercial industry leaders with the objective of adding physiological and molecular imaging capabilities to widely available ultrasound devices.

Our Photo-Acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. We’re proud to have a growing global installed base of leading institutions using our Nexus 128 system, the only fully 3D imaging solution for imaging anatomy, physiology and labeled molecular targets.

Our Thermo-Acoustic technology will enable clinicians to use their existing ultrasound equipment to visualize tissue health, function and composition more clearly – at the point of care. This directly aligns with current healthcare trends to improve patient access, clinical effectiveness, safety and cost.

ENDRA Life Sciences